Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview

NEXT STORY
Novan to Report Second Quarter 2021 Financial Results on August 12, 2021
PREV STORY
Allergies in Primary Care: A Study of the Allergy Management Evaluation Tool Published on Consultant360 Specialty Network
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Investor briefing to be webcast from Chicago on June 3, 2017 at 6:15 PM ...

author_avatar
NASDAQ Market News

Global Clinical Trials Trends and Recent Advancements Report 2019: Year Over Year Clinical Trials in Top 10 Therapy Areas, 2007-2018

Dublin, Jan. 30, 2019 (GLOBE NEWSWIRE) -- The "Global Clinical Trials - Current Trends ...

author_avatar
NASDAQ Market News

Genocea Appoints Ron Cooper to Board of Directors

CAMBRIDGE, Mass., June 09, 2016 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical ...

author_avatar
NASDAQ Market News